Issue Date | Title | Author(s) |
2006 | Biologic treatments in rheumatoid arthritis and juvenile idiopathic arthritis | Borg, Andrew A. |
2012 | Calcium, vitamin D and bone | Borg, Andrew A. |
2014 | Cardiovascular risk assessment and management in rheumatoid arthritis : are guidelines being followed? | Magro, Rosalie; Buhagiar, Malcolm; Taliana, Nikita; Borg, Andrew A. |
2010 | Concordance of gout management with European League against Rheumatism recommendations in hospital practice | Mercieca, Cecilia; Attard Cortis, Petramay; Coleiro, Bernard; Borg, Andrew A. |
2013 | Concordance with the British Society of Rheumatology (BSR) 2010 recommendations on eligibility criteria for the first biologic agent | Frendo, Michela; Caruana Galizia, John Paul; Borg, Andrew A. |
2017 | Determining the presence of peripheral arterial disease in patients with rheumatoid arthritis | Grech, Andrea Celeste; Gatt, Alfred; Borg, Andrew A.; Formosa, Cynthia |
2014-03 | Development and validation of medication assessment tools specific for rheumatoid arthritis | Grech, Louise; Coleiro, Bernard; Borg, Andrew A.; Serracino-Inglott, Anthony; Ferrito, Victor; Azzopardi, Lilian M. |
2013-08 | Documenting and assessing the pharmaceutical care service within a rheumatology department : a 5 year overview | Grech, Louise; Borg, Andrew A.; Coleiro, Bernard; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
2022 | The effect of calcitriol on the expression of interferon signature genes in dendritic cells and macrophages in systemic lupus erythematosus | Magro, Rosalie; Seria, Elisa; Grech, Godfrey; Borg, Andrew A.; Scerri, Christian A. |
2009-11 | The effects of treatment on the quality of life in rheumatoid arthritis | Falzon, S.; Serracino-Inglott, Anthony; Azzopardi, Lilian M.; Anastasi, Alison; Azzopardi, Lilian M.; Borg, Andrew A.; Coleiro, Bernard; Cassar, Paul John; Camilleri, Florinda; Cassar, K.; Mallia, Carmel |
2013 | Evaluation of the impact of a pharmaceutical care service offered to rheumatoid arthritis patients within an ambulatory setting | Grech, Louise; Coleiro, Bernard; Borg, Andrew A.; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
2012 | Freedom of movement across the EU : legal and ethical issues for children with chronic disease | Mercieca, Cecilia; Aquilina, Kevin; Pullicino, Richard; Borg, Andrew A. |
2014-03 | Identification of pharmaceutical care needs for rheumatoid arthritis patients on methotrexate | Grech, Louise; Coleiro, Bernard; Borg, Andrew A.; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
2016 | Peripheral arterial disease screening using the ankle brachial pressure index to identify the cardiovascular disease risk in rheumatoid arthritis | Grech, Andrea Celeste; Formosa, Cynthia; Borg, Andrew A. |
2011-10 | Pharmaceutical care in the management of paediatric rheumatology patients | Grech, Louise; Aquilina, Doris; Azzopardi, Lilian M.; Serracino-Inglott, Anthony; Ferrito, Victor; Borg, Andrew A. |
1993 | Seronegative spondyloarthropathies : a review : part I: classification and differential diagnosis | Borg, Andrew A.; Dawes, Peter T.; Hothersall, T.E. |
1993 | Seronegative spondyloarthropathies : a review : part II: genetics and pathogenesis | Borg, Andrew A.; Dawes, Peter T.; Hothersall, T.E. |
2017 | Translation and validation of the Fatigue Severity Scale, Pittsburgh Sleep Quality Index and Modified Health Assessment Questionnaire into the Maltese language, in a cohort of Maltese Systemic Lupus Erythematosus patients | Magro, Rosalie; Camilleri, Liberato; Borg, Andrew A. |
2021 | Vitamin D supplementation in systemic lupus erythematosus : relationship to disease activity, fatigue and the interferon signature gene expression | Magro, Rosalie; Saliba, Christian; Camilleri, Liberato; Scerri, Christian A.; Borg, Andrew A. |